Sirukumab: a promising therapy for rheumatoid arthritis.

about

Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients.

P2860

Q55417294-F29D6545-B60C-4057-81EA-71AC2F3ED4B7

P2860

Sirukumab: a promising therapy for rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q38856800

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Sirukumab: a promising therapy for rheumatoid arthritis.

@en

type

Item

label

Sirukumab: a promising therapy for rheumatoid arthritis.

@en

prefLabel

Sirukumab: a promising therapy for rheumatoid arthritis.

@en

P1476

Sirukumab: a promising therapy for rheumatoid arthritis.

@en

P2093

Alexandros A Drosos

http://www.w3.org/2001/XMLSchema#string

Paraskevi V Voulgari

http://www.w3.org/2001/XMLSchema#string

P2860

The changing landscape of biosimilars in rheumatology

A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective

Emerging Therapies for Rheumatoid Arthritis

A meta-analysis of cytokines in major depression

Rheumatoid arthritis.

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial

Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapy.

Muscle-derived interleukin-6: mechanisms for activation and possible biological roles.

Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review.

Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study.

P304

755-763

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14712598.2017.1315099

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eleftherios Pelechas

P577

2017-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28374627

http://www.w3.org/2001/XMLSchema#string

Sirukumab: a promising therapy for rheumatoid arthritis.

about

P2860

P2860

Sirukumab: a promising therapy for rheumatoid arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698